The potential use of CCL-2 as a biomarker in anaphylaxis was examined by one group (21), who measured CCL-2 at 3 time points (during the anaphylactic episode and in convalescent samples 7 and 30 days later) in 31 patients presenting to the emergency department with anaphylaxis. Here, CCL2 is linked to anaphylaxis.